Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-05
DOI
10.1038/s41467-018-06741-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The spread and evolution of rabies virus: conquering new frontiers
- (2018) Christine R. Fisher et al. NATURE REVIEWS MICROBIOLOGY
- Lassa fever–induced sensorineural hearing loss: A neglected public health and social burden
- (2018) Elizabeth J. Mateer et al. PLoS Neglected Tropical Diseases
- Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development
- (2018) Hoai J. Hallam et al. npj Vaccines
- Fcγ Receptor Function and the Design of Vaccination Strategies
- (2017) Stylianos Bournazos et al. IMMUNITY
- Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis
- (2017) David M Pigott et al. LANCET
- Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
- (2017) Chad E Mire et al. NATURE MEDICINE
- Structural basis for antibody-mediated neutralization of Lassa virus
- (2017) Kathryn M. Hastie et al. SCIENCE
- An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
- (2017) Qianqian Li et al. VACCINE
- Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein
- (2017) Clara Galan-Navarro et al. VIROLOGY
- A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
- (2017) Kathleen A. Cashman et al. Human Vaccines & Immunotherapeutics
- Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study
- (2017) Catherine F. Houlihan et al. PLOS MEDICINE
- Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies
- (2016) Robert W. Cross et al. ANTIVIRAL RESEARCH
- An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
- (2016) Augustine Goba et al. JOURNAL OF INFECTIOUS DISEASES
- An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
- (2016) Reed F. Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
- (2016) Christoph Wirblich et al. JOURNAL OF VIROLOGY
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever
- (2016) Lisa Oestereich et al. PLoS Pathogens
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus
- (2015) Kristian G. Andersen et al. CELL
- A constant threat for HIV: Fc-engineering to enhance broadly neutralizing antibody activity for immunotherapy of the acquired immunodeficiency syndrome
- (2015) Falk Nimmerjahn EUROPEAN JOURNAL OF IMMUNOLOGY
- Suppression of Fcγ-Receptor-Mediated Antibody Effector Function during Persistent Viral Infection
- (2015) Douglas H. Yamada et al. IMMUNITY
- Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses
- (2015) Mallory Willet et al. JOURNAL OF INFECTIOUS DISEASES
- Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus–Based Filovirus Vaccines
- (2015) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Mapping the zoonotic niche of Lassa fever in Africa
- (2015) Adrian Q. N. Mylne et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
- (2015) Falk Nimmerjahn et al. TRENDS IN IMMUNOLOGY
- International External Quality Assessment Study for Molecular Detection of Lassa Virus
- (2015) Sergejs Nikisins et al. PLoS Neglected Tropical Diseases
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
- (2015) Rami Sommerstein et al. PLoS Pathogens
- Interferon-γ Inhibits Ebola Virus Infection
- (2015) Bethany A. Rhein et al. PLoS Pathogens
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
- (2015) David Safronetz et al. Scientific Reports
- Rhabdovirus-Based Vaccine Platforms against Henipaviruses
- (2014) Drishya Kurup et al. JOURNAL OF VIROLOGY
- GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
- (2014) Christopher H. Clegg et al. PLoS One
- Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: Implication for post-exposure treatment
- (2013) Amy B. Papaneri et al. VACCINE
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- Pathogenesis of the Viral Hemorrhagic Fevers
- (2012) Slobodan Paessler et al. Annual Review of Pathology-Mechanisms of Disease
- Mouse model recapitulating human Fc receptor structural and functional diversity
- (2012) P. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model
- (2012) Marco A. Goicochea et al. VACCINE
- Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
- (2012) Amy B. Papaneri et al. VACCINE
- A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
- (2012) Amy B. Papaneri et al. VIROLOGY
- The Curious Case of Arenavirus Entry, and Its Inhibition
- (2012) Jack H. Nunberg et al. Viruses-Basel
- Pathogenesis of Lassa Fever
- (2012) Nadezhda E. Yun et al. Viruses-Basel
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report
- (2011) Luis M Branco et al. Virology Journal
- A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- (2010) Rhea N. Coler et al. PLoS One
- Fc RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
- (2010) F. Nimmerjahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
- (2010) Luis M Branco et al. Virology Journal
- T Cell-Dependence of Lassa Fever Pathogenesis
- (2010) Lukas Flatz et al. PLoS Pathogens
- Study of Andes virus entry and neutralization using a pseudovirion system
- (2009) Neelanjana Ray et al. JOURNAL OF VIROLOGICAL METHODS
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms
- (2009) Luis M Branco et al. Virology Journal
- Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding
- (2008) Megan M Illick et al. Virology Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now